1-12 of 12
Mi Rim Choi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Vijayalakshmi Chandrasekaran, Yali Liang, Suzette Girgis, Cuiping Chen, Robert Iannone, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2023) 142 (Supplement 1): 1498.
https://doi.org/10.1182/blood-2023-172577
Published: 2023
Journal Articles

Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Luke Maese, Mignon L. Loh, Mi Rim Choi, Yali Liang, Etsuko Aoki, Shane Roller, Tong Lin, Shirali Agarwal, Vijayalakshmi Chandrasekaran, Robert Iannone, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2023) 142 (Supplement 1): 5908.
https://doi.org/10.1182/blood-2023-179533
Published: 2023
Journal Articles

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study

Clinical Trials & Observations
Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2023) 141 (7): 704–712.
https://doi.org/10.1182/blood.2022016923
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy, Safety, and Population Pharmacokinetic Modeling of Intravenous Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma: Results from Study AALL1931

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Xiaotian Wu, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2022) 140 (Supplement 1): 8969–8970.
https://doi.org/10.1182/blood-2022-160192
Published: 2022
Journal Articles

Initial Results from a Phase 2/3 Study of Recombinant Erwinia Asparaginase (JZP458) in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Who Are Allergic/Hypersensitive to E. coli-Derived Asparaginases

Luke Maese, Mignon L. Loh, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Jeffrey A. Silverman, Mi Rim Choi, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Journal: Blood
Blood (2021) 138 (Supplement 1): 2307.
https://doi.org/10.1182/blood-2021-147023
Published: 2021
Journal Articles

A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Healthy Adults

Martha Hernandez-Illas, Tong Lin, Andres Rey, Jack Jenkins, Reddy Chandula, Mi Rim Choi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3817.
https://doi.org/10.1182/blood-2019-123695
Published: 2019
Journal Articles

Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens ( RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to Escherichia coli -Derived Asparaginases

Luke Maese, DO, Rachel E. Rau, MD, Elizabeth A. Raetz, MD, Tong Lin, Jin Zhu, Pil Kim, Reddy Chandula, Sherrie McClung, Julie Gray, Mi Rim Choi, MD, Mignon L. Loh, MD, Peter C. Adamson
Journal: Blood
Blood (2019) 134 (Supplement_1): 2586.
https://doi.org/10.1182/blood-2019-123710
Published: 2019
Journal Articles

Safe and Effective Treatment of Patients with Peripheral T-Cell Lymphoma (PTCL) with the Novel HDAC Inhibitor, Belinostat, in Combination with CHOP: Results of the Bel-CHOP Phase 1 Trial

Patrick B. Johnston, MD PhD, Amanda F. Cashen, MD, Petros G. Nikolinakos, MD, Anne W Beaven, MD, Stefan Klaus Barta, MDMRCP,MS, Gajanan Bhat, PhD, Tao Song, Mi Rim Choi, MD, Lee F. Allen, MD PhD, Sven de Vos, MD PhD, Yasuhiro Oki, MD, Changchun Deng, MDPhD, Francine M Foss, MD
Journal: Blood
Blood (2015) 126 (23): 253.
https://doi.org/10.1182/blood.V126.23.253.253
Published: 2015
Journal Articles

Safe and Effective Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) and Low Baseline Platelet Counts with Belinostat

Kerry J. Savage, MD MSc, Steven M. Horwitz, MD, Pier Luigi Zinzani, MD, PhD, Achiel Van Hoof, Sarit E. Assouline, MD, Gajanan Bhat, Mi Rim Choi, Lee F Allen, Dina Ben-Yehuda, MD, Wojciech Jurczak, Tamas Masszi, MD, Andrei R. Shustov, MD
Journal: Blood
Blood (2014) 124 (21): 3075.
https://doi.org/10.1182/blood.V124.21.3075.3075
Published: 2014
Journal Articles

Subsequent Hematopoietic Stem Cell Transplantation in Belinostat-Treated Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Andrei R. Shustov, MD, Haifa Kathrin Al-Ali, MD, Gerald Wulf, MD, Pamela Hsu, Mi Rim Choi, Lee F Allen, Otto J Visser, MD, Pierre Zachee, MD PhD, Steven M. Horwitz, MD
Journal: Blood
Blood (2014) 124 (21): 5438.
https://doi.org/10.1182/blood.V124.21.5438.5438
Published: 2014
Journal Articles

Patterns of Granulocyte Colony-Stimulating Factor (G-CSF) Use in Elderly Patients with Non-Hodgkin's Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy

John H Page, MD, ScD, Craig Solid, PhD, Victoria M Chia, PhD, Anne Hudson Blaes, MD, Richard L. Barron, Mi Rim Choi, MD, Thomas J Arneson, MD, MPH
Journal: Blood
Blood (2012) 120 (21): 5078.
https://doi.org/10.1182/blood.V120.21.5078.5078
Published: 2012
Journal Articles

Novel treatment for severe congenital neutropenia with pegfilgrastim

L. Mi Rim Choi, Christine Guelcher, Michael F. Guerrera
Journal: Blood
Blood (2007) 110 (12): 4134.
https://doi.org/10.1182/blood-2007-08-106807
Published: 2007